http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2707264-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f88a73255b54f71dce895c684ad98c08 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-007 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F9-00821 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-008 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F9-007 |
| filingDate | 2018-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9639778aaed59db56174a88f071848b1 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1a6d52b6c70714ce7e3739a5778a2b9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ce53a8e9b53d233a392372e11e6f4dc0 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_984badf8979a10526c1a682161d73a27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ca6e535071c060424e34c8610442de3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_46403d82869be7399ed67ba59b962166 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0759dd689a0174dc8aea76599b5e8de6 |
| publicationDate | 2019-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2707264-C1 |
| titleOfInvention | Method of stem cell transplantation in retinal pigment epithelium in experiment |
| abstract | FIELD: medicine.SUBSTANCE: invention relates to medicine, specifically to ophthalmology. Vitrectomy is performed for transplantation of stem cells in case of retinal pigment epithelium (RPE) damage in experimental rabbit. Between the pigment epithelium and neuroepithelium, a stem cell suspension in amount of 50.000 cells in 100 mcl of the BSS solution is introduced to form a bladder. Place of introduction is plugged with PFOC in amount required for radial smoothening and displacement of the bladder with cells from the point of introduction. Endolaser coagulation is performed around the stem cells and PFOC is removed.EFFECT: method provides the possibility of studying the effects of stem cells administration in the damage of pigment epithelium of various genesis in the conditions of minimal injury of retinal layers, long-term integration of stem cells, restoration of function RPE in area of degeneration of pigment epithelium for development of the subsequent method of treatment of degenerative-dystrophic diseases of retina.1 cl, 1 ex |
| priorityDate | 2018-09-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 34.